Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
2004-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36326793f5cd2dd51343c4894ea847a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_214fad0056056bc3241ca29af8ab6b5e |
publicationDate |
2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7488728-B2 |
titleOfInvention |
Pyridinylmorpholine derivatives |
abstract |
The invention relates to compounds of formula (I): n n n n n n n n n n n n wherein R, R 1 , R 2 and X are defined herein, their preparation, and their use as pharmaceuticals. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9382237-B2 |
priorityDate |
2003-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |